Hypertension is the most common modifiable cardiovascular risk factor, the most consistently undertreated, and the condition where the gap between appearing controlled and actually being controlled is widest. Most patients on antihypertensive medication believe their blood pressure is managed. The evidence suggests the actual rate of true control is considerably lower than that belief implies.
The problem starts with how blood pressure is measured. A single reading taken in a clinic setting, with the patient sitting in a waiting room, navigating traffic to get there, and anxious about the visit, does not reflect ambulatory blood pressure. White coat hypertension is real and well documented. Masked hypertension — normal readings in the office and elevated readings outside it — is equally real and considerably more dangerous, because it goes undetected and untreated. A patient whose office readings look fine and who is told their blood pressure is controlled may have consistently elevated pressure at home, at work, and during the low-grade stress that constitutes an ordinary Tuesday.
The solution is systematic home blood pressure monitoring, interpreted over time by a physician who has the context to know what the readings mean. Dr. Stein evaluates blood pressure using a combination of in-office readings, home monitoring protocols, and, where indicated, 24-hour ambulatory monitoring. The picture that emerges from that data is more clinically accurate than any single clinic reading, and the treatment decisions that follow from it are better calibrated accordingly.
Medication selection is the second area where management often falls short. Not all antihypertensive medications work the same way across all patients. ACE inhibitors and ARBs have different tolerability profiles and specific indications. Calcium channel blockers and beta-blockers address different physiological mechanisms and carry different metabolic consequences. Diuretics interact with electrolyte balance, kidney function, and other medications. A patient started on a first-line medication who does not achieve target blood pressure may need a different medication, a different dose, or a combination approach. What they often get is a prescription refill without reassessment.
Contributing factors are consistently undertreated in conventional hypertension management. Sleep apnea is an independent driver of hypertension that is frequently missed in patients without obvious symptoms. Sodium intake, potassium balance, alcohol consumption, and physical activity all have measurable effects on blood pressure that medication cannot fully compensate for. Stress physiology — sustained elevations in cortisol and sympathetic tone — maintains blood pressure elevation even when every other variable is addressed. A physician managing hypertension comprehensively addresses these contributing factors rather than titrating medication against a single number. Chronic disease management at this level of depth is what the condition actually requires.
Medication interactions are the other place where management breaks down in fragmented conventional care. A patient taking an antihypertensive who starts a NSAID for joint pain, adds a decongestant for a sinus infection, and is prescribed a stimulant-class medication by another provider is on a combination that actively undermines their blood pressure control. No individual prescriber sees the full picture. The primary care physician with the complete medication list who reviews it in the context of blood pressure trends is the only physician positioned to identify that interaction. In a concierge practice with a limited panel and longitudinal records, that physician exists and has time to do that work.
Target blood pressure ranges have become more precise in recent years. Current cardiovascular guidelines have lowered recommended targets based on outcome data showing that tighter control produces meaningfully better cardiovascular event rates. Many patients being managed to older, less aggressive targets are at elevated risk that their current treatment does not reflect. Reviewing whether targets are current and whether treatment is achieving them is part of what a comprehensive hypertension evaluation at BRCM addresses.
The consequence of inadequate control is not abstract. Hypertension is the leading risk factor for stroke, a major contributor to heart attack risk, a driver of renal disease progression, and associated with cognitive decline through cerebrovascular mechanisms. In a patient with no symptoms from their blood pressure — which is most patients — the damage accumulates silently until it does not. The window for intervention is years before that point, and it requires a physician willing to look carefully at whether control is real rather than assuming it because the most recent office reading was acceptable.
For members managing hypertension or for patients who want to know whether their blood pressure is truly controlled, the conversation starts with a comprehensive evaluation. Cardiovascular risk in the context of hypertension requires the same depth of assessment that other risk factors receive. The American Heart Association hypertension guidelines provide the current clinical standard that Dr. Stein’s management reflects, including updated target ranges and the expanded role of out-of-office monitoring in evaluating true control.
Call (561) 483-5500 or schedule through the contact page to discuss your blood pressure management directly.